Prudential Financial
TARS icon

Prudential Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

Prudential Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Buy
6,930
+705
+11% +$45K ﹤0.01% 1963
2026
Q1 		$437K Buy
6,225
+3,615
+139% +$253K ﹤0.01% 1903
2025
Q4 		$214K Sell
2,610
-2,950
-53% -$220K ﹤0.01% 2066
2025
Q3 		$330K Sell
5,560
-176,840
-97% -$8.71M ﹤0.01% 2075
2025
Q2 		$7.39M Buy
182,400
+61,595
+51% +$2.77M 0.01% 738
2025
Q1 		$6.21M Sell
120,805
-27,930
-19% -$1.38M 0.01% 754
2024
Q4 		$8.24M Buy
148,735
+45,240
+44% +$2.05M 0.01% 687
2024
Q3 		$3.4M Buy
103,495
+23,980
+30% +$674K ﹤0.01% 1182
2024
Q2 		$2.16M Buy
+79,515
New +$2.67M ﹤0.01% 1384

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Prudential Financial's TARS Position: Q2 2026 in Review

Prudential Financial increased its Tarsus Pharmaceuticals (TARS) stake by 11% in Q2 2026, buying an estimated $45K and bringing the position to 6,930 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #1963.

Prudential Financial first reported a position in TARS in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.24M in Q4 2024. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Prudential Financial held 6,930 shares of Tarsus Pharmaceuticals worth $436K as of Q2 2026.
  • Prudential Financial bought 705 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $45K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1963 holding.
  • Prudential Financial first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Prudential Financial's Tarsus Pharmaceuticals position peaked at $8.24M in Q4 2024.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.